News | March 22, 2022
Barentz acquires life science ingredients, specialty chemicals distributor Divsa
Divsa's coverage across Central America bridges Barentz' leading positions in North and South America
Divsa's coverage across Central America bridges Barentz' leading positions in North and South America
Sputnik Light is the first component of Sputnik V
Inconsistent antibody performance is a significant challenge for researchers and sits at the heart of the reproducibility crisis observed in biomedical research
Under the agreement, Lonza will deliver cGMP-standard drug substance for clinical supply
At the interim analysis, the combination of Keytruda and Lynparza did not demonstrate a benefit in overall survival (OS), one of the study’s dual primary endpoints, compared to the control arm of either abiraterone acetate or enzalutamide
EUROAPI listing on Euronext Paris will occur in H1 2022, despite volatile market conditions
Prashant comes with over 17 years of experience in the health, health insurance and other allied healthcare sectors
The investment will accelerate the overall Sarclisa development program
Jointly fund and develop up to three antibody-drug conjugate programs for the treatment of cancer
Deploying solutions like Uniphore’s U-Self Serve and U-Assist with SpinSci’s Patient Engage and Patient Assist is an important step forward in creating frictionless patient experiences
Subscribe To Our Newsletter & Stay Updated
